Literature DB >> 163869

Seroepidemiologic study of Epstein-Barr virus infections in a rural community.

C V Sumaya, W Henle, G Henle, M H Smith, D LeBlanc.   

Abstract

The prevalence and titers of antibodies to capsid antigens of Epstein-Barr virus ad to the diffuse and restricted components of the Epstein-Barr virus-induced early antigen complex were determined in 109 families of a semirural community in Louisiana. Titers of antibody to the capsid antigens larger than or equal to 10 were found in 84 percent of children aged two to five years, and the prevalence increased with age to nearly 100 percent. There was a positive but variable correlation of the prevalence of anti-capsid antigen reactivity with low socioeconomic status and crowding. An overrepresentation of high titers of antibody to capsid antigens was present in individuals with a past history of pneumonia and urinary tract infections. The geometric mean titers of antibody to capsid antigens were highest in early childhood, lowest in adolescence and young adulthood, and high in the elderly. Females in all age groups and tonsillectomized children showed a higher geometric mean titer than their male and nontonsillectomized counterparts, respectively. Antibodies to the early antigen complex were found rarely (8.2 percent) and only in sera with relatively high titers of antibody to capsid antigens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163869     DOI: 10.1093/infdis/131.4.403

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

Review 1.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  EB virus antibody and infectious mononucleosis in a boarding school for boys.

Authors:  T W Hoskins; W B Fletcher; J M Blake; M S Pereira; J M Edwards
Journal:  J Clin Pathol       Date:  1976-01       Impact factor: 3.411

3.  Measurement of heterophil antibody and antibodies to EB viral capsid antigen IgG and IgM in suspected cases of infectious mononucleosis.

Authors:  J M Blake; J M Edwards; W Fletcher; D A McSwiggan; M S Pereira
Journal:  J Clin Pathol       Date:  1976-09       Impact factor: 3.411

4.  Laboratory diagnosis of EB virus infection in some cases presenting as hepatitis.

Authors:  J M Edwards; E M Vandervelde; B J Cohen; D A McSwiggan
Journal:  J Clin Pathol       Date:  1978-02       Impact factor: 3.411

5.  Epstein-Barr virus early antigen titer by immunofluorescence in microplates. A new semi-automated method based on microtiter system.

Authors:  A M Favart; M E Lamy; D Allemeersch; G Burtonboy; J Vanoverschelde
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

6.  Epidemiology of Epstein-Barr virus infection in pre-adolescent children: application of a new salivary method in Edinburgh, Scotland.

Authors:  N S Crowcroft; A Vyse; D W Brown; D P Strachan
Journal:  J Epidemiol Community Health       Date:  1998-02       Impact factor: 3.710

Review 7.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

8.  The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: comparison of serum antibody titre, cellular antigen content and histopathology.

Authors:  N Falser
Journal:  Arch Otorhinolaryngol       Date:  1984

9.  EB virus-specific IgA in serum of patients with infectious mononucleosis and of healthy people of different ages.

Authors:  J M Edwards; M Woodroof
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

10.  Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women.

Authors:  Jennifer A Slyker; Corey Casper; Kenneth Tapia; Barbra Richardson; Lisa Bunts; Meei-Li Huang; Elizabeth Maleche-Obimbo; Ruth Nduati; Grace John-Stewart
Journal:  J Infect Dis       Date:  2013-03-14       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.